# FDA 483 - Lucid Laboratories Private Limited - March 08, 2024

Source: https://www.keypedia.com/records/483/lucid-laboratories-private-limited/8a65232b-a490-42c3-aced-2e66248d68f7

> FDA 483 for Lucid Laboratories Private Limited on March 08, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lucid Laboratories Private Limited
- Inspection Date: 2024-03-08
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: An FDA inspection of Lucid Laboratories Private Limited, a control testing laboratory in Hyderabad, India, from March 6-8, 2024, revealed significant deficiencies in its quality control unit. The firm failed to follow written procedures for documenting standards lists and deviated from specified test method parameters, including injection volumes, without notifying customers. These issues indicate a lack of adherence to established quality control processes.

## Related Officers

- [Investigator ](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)

Company: https://www.keypedia.com/companies/lucid-laboratories-private-limited/d6b6222b-d9d0-428c-9408-bcb793aca8d1

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3